The effects of tobacco use on oral health

Hong Kong Medical Journal

Volumn 9, Issue 4, 2003, Pages 271-277

  Sham, A S K ^a   Cheung, L K ^a   Jin, L J ^a   Corbet, E F ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Dental implants; Mouth neoplasms; Periodontal diseases; Smoking; Tobacco

Indexed keywords

AMFEBUTAMONE; CARCINOGEN; CYTOKINE; FORMALDEHYDE; INTERLEUKIN 1; NICOTINE; NICOTINE GUM; NITROSAMINE; POLYCYCLIC AROMATIC COMPOUND;

ALCOHOL CONSUMPTION; BETEL NUT; BONE; CANCER INCIDENCE; CANCER RISK; DENTAL CARE; DENTAL CARIES; DISEASE COURSE; DISEASE SEVERITY; ERYTHROPLASIA; EVIDENCE BASED MEDICINE; GINGIVA BLEEDING; GINGIVA DISEASE; GINGIVITIS; HALITOSIS; HEALTH; HUMAN; INHALER; KERATOSIS; LEUKOPLAKIA; LOZENGE; MASTICATION; MEDLINE; MOUTH CANCER; MOUTH HYGIENE; NICOTINE REPLACEMENT THERAPY; PERIODONTAL DISEASE; PERIODONTITIS; PRECANCER; PREVALENCE; REVIEW; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; SQUAMOUS CELL CARCINOMA; TABLET; TASTE DISORDER; TOBACCO DEPENDENCE; TOOTH CALCULUS; TOOTH IMPLANTATION; TRANSDERMAL PATCH; TREATMENT FAILURE; TREATMENT OUTCOME; VASOCONSTRICTION; VERRUCOUS CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COUNSELING; DENTAL IMPLANTS; HUMANS; MOUTH NEOPLASMS; ORAL HEALTH; PERIODONTAL DISEASES; PROSTHESIS FAILURE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 0041662143     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Wald NJ, Hackshaw AK. Cigarette smoking: an epidemiological overview. Br Med Bull 1996;52:3-11.
2. Haas R, Haimbock W, Mailath G, Watzek G. The relationship of smoking on peri-implant tissue: a retrospective study. J Prosthet Dent 1996;76:592-6.
3. Asmussen E, Hansen EK. Surface discoloration of restorative resins in relation to surface softening and oral hygiene. Scand J Dent Res 1986;94:174-7.
4. Mehta FS, Jalnawalla PN, Daftary DK, Gupta PC, Pindborg JJ. Reverse smoking in Andhra Pradesh, India: variability of clinical and histologic appearances of palatal changes. Int J Oral Surg 1977;6:75-83.
5. Hedin CA, Pindborg JJ, Axell T. Disappearance of smoker's melanosis after reducing smoking. J Oral Pathol Med 1993;22:228-30.
6. Holmgren CJ, Corbet EF, Lim, LP. Periodontal conditions among the middle-aged and the elderly in Hong Kong. Community Dent Oral Epidemiol 1994;22:396-402.
7. Ravald N, Birkhed D, Hamp SE. Root caries susceptibility in periodontally treated patients. Results after 12 years. J Clin Periodontol 1993;20:124-9.
8. Bergstrom J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989:17:245-7.
9. Amarasena N, Ekanayaka AN, Herath L, Miyazaki H. Tobacco use and oral hygiene as risk indicators for periodontitis. Community Dent Oral Epidemiol 2002;30:115-23.
10. Haber J, Kent RL. Cigarette smoking in a periodontal practice. J Periodontol 1992;63:100-6.
11. Bergstrom J. Tobacco smoking and supragingival dental calculus. J Clin Periodontol 1999;26:541-7.
12. Muller HP, Stadermann S, Heinecke A. Longitudinal association between plaque and gingival bleeding in smokers and non-smokers. J Clin Periodontol. 2002;29:287-94.
13. , Martinez-Canut P, Lorca A, Magan R. Smoking and periodontal disease severity. J Clin Periodontol 1995;22:743-9.
14. Machuca G, Rosales I, Lacalle JR, Machuca C, Bullon P. Effect of cigarette smoking on periodontal status of healthy young adults. J Periodontol 2000;71:73-8.
15. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000;71:743-51.
16. Grossi SG, Zambon JJ, Ho AW, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-7.
17. Horning GM, Cohen ME. Necrotizing ulcerative gingivitis, periodontitis, and stomatitis: clinical staging and predisposing factors. J Periodontol 1995;66:990-8.
18. Johnson BD, Engel D. Acute necrotizing ulcerative gingivitis. A review of diagnosis, etiology and treatment. J Periodontol 1986;57:141-50.
19. Slots J, Contreras A. Herpesviruses: a unifying causative factor in periodontitis? Oral Microbiol Immunol 2000;15:277-80.
20. Clarke NG, Shephard BC, Hirsch RS. The effects of intra-arterial epinephrine and nicotine on gingival circulation. Oral Surg Oral Med Oral Pathol 1981;52:577-82.
21. Tipton DA, Dabbous MK. Effects of nicotine on proliferation and extracellular matrix production of human gingival fibroblasts in vitro. J Periodontol 1995;66:1056-64.
22. Travis J, Pike R, Imamura T, Potempa J. The role of proteolytic enzymes in the development of pulmonary emphysema and periodontal disease. Am J Respir Crit Care Med 1994;150:143S-146S.
23. Bergstrom J, Preber H. Tobacco use as a risk factor. J Periodontol 1994;65(5 Suppl):545S-550S.
24. Meisel P, Siegemund A, Dombrowa S, Sawaf H, Fanghaenel J, Kocher T. Smoking and polymorphisms of the interleukin-1 gene cluster (IL-1alpha, IL-1beta, and IL-1RN) in patients with periodontal disease. J Periodontol 2002;73:27-32.
25. Preber H, Linder L, Bergstrom J. Periodontal healing and periopathogenic microflora in smokers and non-smokers. J Clin Periodontol 1995;22:946-52.
26. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ. Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996;67(10 Suppl):1094S-1102S.
27. Bostrom L, Linder LE, Bergstrom J. Influence of smoking on the outcome of periodontal surgery. A 5-year follow-up. J Clin Periodontol 1998;25:194-201.
28. Ah MK, Johnson GK, Kaldahl WB, Patil KD, Kalkwarf KL. The effect of smoking on the response to periodontal therapy. J Clin Periodontol 1994;21:91-7.
29. Norderyd O, Hugoson A. Risk of severe periodontal disease in a Swedish adult population. A cross-sectional study. J Clin Periodontol 1998;25:1022-8.
30. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontol 1996;67:675-81.
31. Grossi SG, Zambon J, Machtei EE, et al. Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997;128:599-607.
32. Trombelli L, Scabbia A. Healing response of gingival recession defects following guided tissue regeneration procedures in smokers and non-smokers. J Clin Periodontol 1997;24:529-33.
33. Trombelli L, Kim CK, Zimmerman GJ, Wikesjo UM. Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in intrabony defects. J Clin Periodontol 1997;24:366-71.
34. Johnson GK, Slach NA. Impact of tobacco use on periodontal status. J Dent Educ 2001;65:313-21.
35. Jin L, Wong KY, Leung WK, Corbet EF. Comparison of treatment response patterns following scaling and root planing in smokers and non-smokers with untreated adult periodontitis. J Clin Dent 2000;11:35-41.
36. Eggert FM, McLeod MH, Flowerdew G. Effects of smoking and treatment status on periodontal bacteria: evidence that smoking influences control of periodontal bacteria at the mucosal surface of the gingival crevice. J Periodontol 2001;72:1210-20.
37. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van der Velden U, Van der Weijden GA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol 2001;28:296-305.
38. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, van der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Periodontol 2001;72:666-71.
39. Worthington H, Clarkson J, Davies R. Extraction of teeth over 5 years in regularly attending adults. Community Dent Oral Epidemiol 1999;27:187-94.
40. Yoshida Y, Hatanaka Y, Imaki M, Ogawa Y, Miyatani S, Tanada S. Epidemiological study on improving the QOL and oral conditions of the aged-Part 2: Relationship between tooth toss and lifestyle factors for adults men. J Physiol Anthropol Appl Human Sci 2001;20:369-73.
41. Ragnarsson E, Eliasson ST, Olafsson SH. Tobacco smoking, a factor in tooth loss in Reykjavik, Iceland. Scand J Dent Res 1992;100:322-6.
42. Widmark G, Andersson B, Carlsson GE, Lindvall AM, Ivanoff CJ. Rehabilitation of patients with severely resorbed maxillae by means of implants with or without bone grafts: a 3- to 5-year follow-up clinical report. Int J Oral Maxillofac Implants 2001;16:73-9.
43. Bain CA, Moy PK. The association between the failure of dental implants and cigarette smoking. Int J Oral Maxillofac Implants 1993;8:609-15.
44. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (II). Etiopathogenesis. Eur J Oral Sci 1998;106:721-64.
45. Wallace RH. The relationship between cigarette smoking and dental implant failure. Eur J Prosthodont Restor Dent 2000;8: 103-6.
46. Lindquist LW, Carlsson GE, Jemt T. Association between marginal bone loss around osseointegrated mandibular implants and smoking habits: a 10-year follow-up study. J Dent Res 1997;76:1667-74.
47. Carlsson GE, Lindquist LW, Jemt T. Long-term marginal periimplant bone loss in edentulous patients. Int J Prosthodont 2000;13:295-302.
48. Bain CA. Smoking and implant failure-benefits of a smoking cessation protocol. Int J Oral Maxillofac Implants 1996;11:756-9.
49. van der Waal I, Axell T. Oral leukoplakia: a proposal for uniform reporting. Oral Oncol 2002;38:521-6.
50. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000;6:1702-10.
51. Shiu MN, Chen TH, Chang SH, Hahn LJ. Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 2000;82:1871-4.
52. The Smokeless Tobacco Products (Prohibition) Regulations (Chapter 132BW), Hong Kong Government.
53. Gupta PC, Bhonsle RB, Murty PR, Mehta FS, Pindborg JJ. Epidemiologic characteristics of treated oral cancer patients detected in a house-to-house survey in Kerala, India. Indian J Cancer 1986;23:206-11.
54. Zavras AI, Douglass CW, Joshipura K, et al. Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. Oral Oncol 2001;37:28-35.
55. Jones A. A general review of the p53 gene and oral squamous cell carcinoma. Ann R Australas Coll Dent Surg 1998;14:66-9.
56. Tanaka N, Odajima T, Mimura M, et al. Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa. Oral Oncol 2001;37:308-14.
57. Hung HC, Chuang J, Chien YC, et al. Genetic polymorphisms CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997;6:901-5.
58. Nair UJ. Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999;20:743-8.
59. Vineis P, Malats N, Lang M, et al. Metabolic polymorphisms and susceptibility to cancer, International Agency for Research on Cancer, IARC Scientific Publications No. 148, Lyon: IARC; 1999.
60. Nair U, Bartsch H. Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ 2001;154:271-90.
61. Katoh T, Kaneko S, Kohshi K, et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999;83:606-9.
62. Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. National Institute for Clinical Excellence Technology Appraisal Guidance No. 39. 2002 Apr. National Institute for Clinical Excellence website: www.nice.org.uk. Accessed December 2002.
63. Rennard SI, Daughton DM. Smoking cessation. Chest 2000;117:(5 Suppl 2):360S-364S.
64. Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA 1999;281:72-6.
65. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999;340:685-91.
66. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000;55:987-99.